Help us: Donate
Follow us on:

Shift Bioscience


Organization Description


Shift Bioscience claims to have identified safer drug targets for cellular rejuvenation by applying machine-learning ‘driver’ clocks to cell reprogramming. The company says that it is on the cusp of validating these targets and is uniquely positioned to do so.


Daniel Ives, Ph.D.

Shift Bioscience - Founder and CEO